Skip to main content
Clinical Trials/CTRI/2019/12/022302
CTRI/2019/12/022302
Completed
未知

A clinical study to evaluate the efficacy of Aparajit Avaleha in the management of Vataja Kasa in children

Department of Kaumarbhritya0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: J069- Acute upper respiratory infection,unspecified
Sponsor
Department of Kaumarbhritya
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 2, 2021
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Kaumarbhritya

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients of Vataja Kasa with symptoms Parshavshool, Shirashool, Urashool, Sawarbheda, Shuska Mukha and Gala as a major symptoms.
  • 2\.Acute Cough of less than 7 days.
  • 3\.Newly diagnosed cases of Vataja Kasa.

Exclusion Criteria

  • 1\.Patients below age of 6 years and above age of 12 years.
  • 2\.Patients with chronic debilitating disease or disorders.
  • 3\.All types of Kasa except Vataja Kasa Lakshana will be excluded.
  • 4\.Conditions like Pneumonia, Juvenile Diabetes Mellitus, Tuberculosis, Bronchiolitis, Asthma \< Chronic Productive Cough, Whooping Cough, Sinusitis, Tonsillitis should be excluded.
  • Cough with High Grade Fever.
  • 5\.If Cough aggravates during treatment then it will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials